The pathobiological basis of depression in Parkinson disease: challenges and outlooks Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 02 November 2022 Pages: 1397 - 1418
Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease Patricia KrauseSara BerkingAndrea A. Kühn Neurology and Preclinical Neurological Studies - Original Article Open access 06 November 2022 Pages: 1419 - 1426
Corticobasal syndrome and Parkinson’s disease at the beginning: asymmetrical patterns of MRI and Blink Reflex for early diagnosis Giulia DonzusoGiorgia SciaccaMario Zappia Neurology and Preclinical Neurological Studies - Original Article Open access 29 October 2022 Pages: 1427 - 1433
Neurexin 2 p.G849D variant, implicated in Parkinson’s disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells Katelyn CuttlerDalene de SwardtSoraya Bardien Neurology and Preclinical Neurological Studies - Original Article 15 October 2022 Pages: 1435 - 1446
Classification of Parkinson’s disease motor phenotype: a machine learning approach Lívia ShirahigeBrenda LeimigKátia Monte-Silva Neurology and Preclinical Neurological Studies - Original Article 06 November 2022 Pages: 1447 - 1461
Perceived social support declines after deep brain stimulation surgery in patients with Parkinson’s disease Sydney SpagnaAsra AskariKelvin L. Chou Neurology and Preclinical Neurological Studies - Original Article 28 October 2022 Pages: 1463 - 1468
Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysis Prabesh KanelC. Chauncey SpearsNicolaas I. Bohnen Neurology and Preclinical Neurological Studies - Original Article 12 October 2022 Pages: 1469 - 1479
Writing tremor in Parkinson’s disease: frequency and associated clinical features Marcello Mario MasciaGianni OrofinoGiovanni Defazio Neurology and Preclinical Neurological Studies - Original Article 26 October 2022 Pages: 1481 - 1485
The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion rates Hannah P. RowePerman GochyyevJordan R. Green Neurology and Preclinical Neurological Studies - Original Article 28 October 2022 Pages: 1487 - 1511
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study Niyazi Samet YilmazBayram SenNeslihan Bukan Psychiatry and Preclinical Psychiatric Studies - Original Article 05 November 2022 Pages: 1513 - 1526